Стоимость терапии стволовыми клетками варьируется от $2000 до $100000 в зависимости от места проведения. Вот что на самом деле влияет на стоимость, что входит в пакет услуг и как Таиланд соотносится с США, Австралией и Европой в 2026 году.
A 2025 clinical trial reports the first-ever strength improvement in ALS patients using intranasally delivered MSC exosomes — zero adverse events across 32 treatments.
PRP has its limits. For serious tendon and ligament injuries, stem cells are showing results PRP cannot match.
A June 2026 study shows that senolytic preconditioning dramatically improves MSC efficacy by removing the SASP factors that suppress tissue repair. Plus: AAT-MSCs reverse diabetes via immune reprogramming, and a phase III MSC trial for meniscal repair reaches completion.
A 2026 real-world study followed 120 refractory lupus nephritis patients treated with UC-MSCs. Cumulative renal response reached 56.7% at 12 months with low relapse rates and zero severe adverse events. Here’s what clinicians need to know.
36-месячное клиническое исследование показало отсутствие побочных эффектов и снижение боли на 571 TP3T при инъекции стволовых клеток в разорванные вращательные манжеты плеча. Вот что нужно знать любителям спорта и спортсменам-любителям о терапии МСК при спортивных травмах.
Every workout floods your bloodstream with stem cells — your body’s own repair crew. Learn how exercise mobilizes regenerative cells and why it matters for aging and healing.
The MERIT phase 1 trial published in Cell Reports Medicine shows that intravenous UC-MSC therapy is safe in subacute ischemic stroke, with early NIHSS improvement signals. Here’s what clinicians need to know.
A 2026 meta-analysis of 15 RCTs shows MSCs cut acute GvHD incidence by 53% and chronic GvHD by 50%. A biomarker-guided trial identifies which transplant patients benefit most — and a cell-free exosome approach may be next.
Your body’s stem cell population drops dramatically after 40. Here’s what the science says about why we age — and how regenerative medicine is fighting back.
Russian 
English 
Chinese 
French